We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Make Trial Participation a Condition of Coverage for Certain New Drugs, Say Experts
Make Trial Participation a Condition of Coverage for Certain New Drugs, Say Experts
The Centers for Medicare and Medicaid Services (CMS) should require clinical trial participation of patients seeking coverage for many new drugs, particularly those that have accelerated approval.